s-nitroso-n-acetylpenicillamine and Fibrosarcoma

s-nitroso-n-acetylpenicillamine has been researched along with Fibrosarcoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alexaki, VI; Alizadeh, N; Ansari, M; Castanas, E; Dehpour, AR; Ebrahimkhani, MR; Khorramizadeh, MR; Nasseh, A; Nifli, AP; Saadat, F; Shariftabrizi, A	1
Duszyk, M; Jurasz, P; Mayers, I; Miranda, C; Radomski, MW; Sawicka, J; Sawicki, G	1

Other Studies

2 other study(ies) available for s-nitroso-n-acetylpenicillamine and Fibrosarcoma

Article	Year
Matrix metalloproteinase 2 secretion in WEHI 164 fibrosarcoma cells is nitric oxide-related and modified by morphine. European journal of pharmacology, 2006, Jan-13, Volume: 530, Issue:1-2 Topics: Animals; Cell Proliferation; Diprenorphine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibrosarcoma; Flow Cytometry; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Morphine; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Receptors, Opioid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; S-Nitroso-N-Acetylpenicillamine; Tumor Cells, Cultured	2006
Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide. Cancer research, 2001, Jan-01, Volume: 61, Issue:1 Topics: Adenosine Diphosphate; Blood Platelets; Cell Communication; Enzyme Inhibitors; Epoprostenol; Fibrosarcoma; Gelatinases; Glutathione; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Neoplasms, Experimental; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Penicillamine; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinoxalines; S-Nitroso-N-Acetylpenicillamine; S-Nitrosoglutathione; Thromboxane A2; Tumor Cells, Cultured	2001

Article

Year

Matrix metalloproteinase 2 secretion in WEHI 164 fibrosarcoma cells is nitric oxide-related and modified by morphine.

European journal of pharmacology, 2006, Jan-13, Volume: 530, Issue:1-2

Topics: Animals; Cell Proliferation; Diprenorphine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibrosarcoma; Flow Cytometry; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Morphine; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Receptors, Opioid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; S-Nitroso-N-Acetylpenicillamine; Tumor Cells, Cultured

2006

Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.

Cancer research, 2001, Jan-01, Volume: 61, Issue:1

Topics: Adenosine Diphosphate; Blood Platelets; Cell Communication; Enzyme Inhibitors; Epoprostenol; Fibrosarcoma; Gelatinases; Glutathione; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Neoplasms, Experimental; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Penicillamine; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinoxalines; S-Nitroso-N-Acetylpenicillamine; S-Nitrosoglutathione; Thromboxane A2; Tumor Cells, Cultured

2001